Interestingly, PBRM1 mutations in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) and esophageal carcinoma (ESCA) correlated with robust responses to all five signatures, increasing and decreasing, respectively (Fig 4B). Here, PBRM1 is linked to cervical squamous cell carcinoma.